Sumitomo Chemical India Q1FY27 profit jumps 20% to ₹215 cr

Stock rises nearly 2% after Q1 print

Shares of Sumitomo Chemical India Ltd gained nearly 2% in early trade on Monday, July 27, after the agrochemical company reported its earnings for the quarter ended June 2026. The results showed profit growth despite revenue staying largely flat year on year. Investors appeared to focus on the improvement in operating performance and a higher EBITDA margin. The company’s Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026 on July 27, 2026. The numbers also included the impact of an insurance claim linked to a prior business interruption event.

Q1FY27 profit grows faster than revenue

For the quarter ended June 2026, the company reported net profit of ₹214.8 crore, up 20.5% from ₹178.3 crore in the year-ago period. Revenue from operations increased marginally by 0.6% year on year to ₹1,063.3 crore compared with ₹1,056.7 crore a year earlier. Operating performance improved, with EBITDA rising 6.1% to ₹217.7 crore from ₹205 crore in the corresponding quarter last year. EBITDA margin expanded to 20.48% from 19.40% a year ago.

Standalone results: insurance claim supports earnings

On a standalone basis, Sumitomo Chemical India reported a 20.4% year-on-year rise in net profit to ₹216.53 crore for the quarter ended June 30, 2026. The company said the performance was aided by an insurance claim of ₹26.90 crore. The insurance claim was received for business interruption following a fire incident at the Bhavnagar plant during FY23. Standalone revenue from operations rose 0.6% year on year to ₹1,054.08 crore. The reported support from the insurance claim is an important line item in understanding the difference between revenue growth and profit growth in the quarter.

Consolidated results: revenue steady, profit higher

On a consolidated basis, revenue from operations stood at ₹1,063.35 crore, a 0.6% increase year on year. Consolidated net profit for the quarter was ₹214.51 crore, up 20.5% year on year. Consolidated net profit attributable to owners of the holding company rose 20.5% to ₹214.83 crore, compared with ₹178.34 crore in the same quarter last year. Other income contributed ₹47.28 crore to the consolidated total, up from ₹38.79 crore in Q1FY26. Total comprehensive income for the group was reported at ₹213.53 crore.

Income statement lines investors tracked

Beyond the headline profit and revenue, the quarter reflected higher other income and controlled operating metrics that helped expand margins. Standalone other income was reported at ₹47.06 crore, while consolidated other income was ₹47.28 crore. Standalone total expenses were ₹836.77 crore and consolidated total expenses were ₹849.29 crore. Profit before tax (PBT) came in at ₹291.26 crore on a standalone basis and ₹288.24 crore on a consolidated basis. These figures help explain the stronger bottom-line outcome even as top-line growth was limited to low single digits.

EBITDA improvement and margin expansion

The company’s operating performance improved year on year, with EBITDA rising to ₹217.7 crore versus ₹205 crore in the year-ago quarter. The EBITDA margin expanded to 20.48% from 19.40%, according to the earnings snapshot shared with the market. In results seasons, margins are closely watched in the agrochemical sector because input costs, product mix, and channel dynamics can shift quickly. In this quarter, the margin expansion was a key positive read-through, especially given that revenue growth was only 0.6%.

Key numbers at a glance

The table below summarises the key reported metrics for the quarter ended June 30, 2026, as presented in the standalone and consolidated financials.

How this compares with the previous year’s quarter

For context, the year-ago quarter referenced in the disclosures included consolidated net profit attributable to owners of ₹178.34 crore. In the same quarter last year, consolidated revenue from operations was around ₹1,056.78 crore, based on the quarterly comparison data shared. In Q1FY27, revenue is broadly at a similar level, while profit has moved higher by about 20%. That gap between revenue growth and profit growth makes the mix of operating performance, other income, and one-off items such as insurance claims especially relevant.

Market impact: what the early move signals

The near-2% rise in early trade on July 27 suggests the market reaction was positive to the combination of higher profit and better operating margin. The quarter’s revenue growth was marginal, but the profit growth was strong on a year-on-year basis. The insurance claim of ₹26.90 crore is also a clear, quantified contributor mentioned in the company’s disclosure. For investors, such items typically matter because they can influence comparability across quarters, especially when the core top line is stable.

Conclusion

Sumitomo Chemical India’s June 2026 quarter showed steady revenue and a sharp year-on-year improvement in profit, supported by margin expansion and a ₹26.90 crore insurance claim related to the FY23 Bhavnagar plant fire incident. With the Board approving the results on July 27, 2026, the market had immediate clarity on the reported drivers. The next updates investors will track are subsequent quarterly disclosures for confirmation of whether operating margin levels remain elevated without similar one-off support.